CN115992091A - A method for isolating and culturing rat bone marrow mesenchymal stem cells - Google Patents
A method for isolating and culturing rat bone marrow mesenchymal stem cells Download PDFInfo
- Publication number
- CN115992091A CN115992091A CN202211683600.3A CN202211683600A CN115992091A CN 115992091 A CN115992091 A CN 115992091A CN 202211683600 A CN202211683600 A CN 202211683600A CN 115992091 A CN115992091 A CN 115992091A
- Authority
- CN
- China
- Prior art keywords
- mesenchymal stem
- stem cells
- isolating
- rat
- bone marrow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于生物技术领域,公开了一种大鼠骨髓间充质干细胞的分离及培养方法,包括:获取大鼠的双侧股骨和胫骨,剔除表面的肌肉,并利用清洗液反复冲洗干净;在无菌条件下,剪除所述双侧股骨和胫骨的两头,并利用清洗液多次冲洗股骨胫骨两端断口;将骨髓冲入培养液中,将细胞悬液直接接种于培养瓶中进行培养,待细胞80%汇合后胰蛋白酶消化传代培养;取健康生长第2代大鼠MSC制成细胞悬液移至离心管中,离心;弃上清液,用清洗液调整细胞浓度;加入兔抗鼠CD45、CD44、CD90单克隆抗体,室温孵育,得到大鼠骨髓间充质干细胞。本发明提供了一种大鼠骨髓间充质干细胞的分离、培养及鉴定方法,操作简单,细胞产量和成活率高。
The invention belongs to the field of biotechnology, and discloses a method for isolating and culturing rat bone marrow mesenchymal stem cells, comprising: obtaining bilateral femurs and tibias of rats, removing the muscles on the surface, and repeatedly rinsing them with a cleaning solution; Under sterile conditions, cut off the two ends of the bilateral femur and tibia, and use the cleaning solution to wash the fractures at both ends of the femur and tibia several times; wash the bone marrow into the culture solution, and inoculate the cell suspension directly in the culture bottle for cultivation. After the cells are 80% confluent, trypsinize and subculture; take the second generation of healthy growing rat MSCs to make a cell suspension, transfer it to a centrifuge tube, and centrifuge; discard the supernatant, and adjust the cell concentration with the cleaning solution; add rabbit anti-mouse CD45, CD44, CD90 monoclonal antibodies were incubated at room temperature to obtain rat bone marrow mesenchymal stem cells. The invention provides a method for isolating, cultivating and identifying rat bone marrow mesenchymal stem cells, which has simple operation and high cell yield and survival rate.
Description
技术领域technical field
本发明属于生物技术领域,尤其涉及一种大鼠骨髓间充质干细胞的分离及培养方法。The invention belongs to the field of biotechnology, in particular to a method for separating and culturing rat bone marrow mesenchymal stem cells.
背景技术Background technique
目前,现有的原代间充质干细胞来源有限,实验研究需大量使用3-5代培养细胞,现有的原代间充质干细胞提取及分离方法操作复杂,细胞产量和成活率低。本方明方法为间充质干细胞的研究和应用提供了丰富的材料来源,广泛存在于骨髓、脐带血、脂肪等组织的间充质干细胞(mesenchymalstemcells,MSCs),具有强大的增殖能力、多向分化潜能、免疫调节功能、来源方便、不存在免疫排斥、无伦理问题等特点,包括MSCs的预处理和扩增、MSCs的条件培养基(Conditionedmedia,CM)、旁分泌因子、分泌蛋白质组、外泌体、细胞外囊泡(Extracellularvesicles,EVs)在内的MSCs衍生物,具有更低的免疫原性、性质稳定、无成瘤及血栓风险等特点,采用MSCs及其衍生物相关细胞疗法和无细胞疗法可能是治疗各种复杂疾病的最佳解决方案。MSCs及其衍生物作为疾病创新疗法的成功很可能取决于更好地理解其的作用机制,以及确定在临床环境中使用它们的最佳策略,因此需要大量的原代间充质干细胞进行实验研究。At present, the existing sources of primary mesenchymal stem cells are limited, and experimental research needs to use a large number of 3-5 passage cultured cells. The existing primary mesenchymal stem cell extraction and isolation methods are complicated to operate, and the cell yield and survival rate are low. The Fangming method provides a rich source of materials for the research and application of mesenchymal stem cells. Mesenchymal stem cells (MSCs) widely exist in bone marrow, umbilical cord blood, fat and other tissues, and have strong proliferation ability, multidirectional Differentiation potential, immunoregulatory function, convenient source, no immune rejection, no ethical issues, etc., including pretreatment and expansion of MSCs, conditioned media (CM) of MSCs, paracrine factors, secretome, extracellular MSCs derivatives including exosomes and extracellular vesicles (Extracellular vesicles, EVs) have the characteristics of lower immunogenicity, stable properties, and no risk of tumor formation and thrombosis. Cell therapy may be the best solution to treat various complex diseases. The success of MSCs and their derivatives as innovative therapies for disease will likely depend on a better understanding of their mechanisms of action, as well as the identification of optimal strategies for their use in clinical settings, thus requiring large numbers of primary MSCs for experimental studies .
通过上述分析,现有技术存在的问题及缺陷为:现有的大鼠骨髓间充质干细胞体外分离及培养方法操作复杂,细胞产量和成活率低。Based on the above analysis, the existing problems and defects of the prior art are: the existing method for in vitro isolation and culture of rat bone marrow mesenchymal stem cells is complicated to operate, and the cell yield and survival rate are low.
发明内容Contents of the invention
针对现有技术存在的问题,本发明提供了一种大鼠骨髓间充质干细胞的分离及培养方法。Aiming at the problems existing in the prior art, the present invention provides a method for isolating and culturing rat bone marrow mesenchymal stem cells.
本发明是通过提取大鼠长骨骨髓中存在的间充质干细胞实现大量原代骨髓间充质干细胞的分离及培养,提供一种大鼠骨髓间充质干细胞的分离及培养方法,所述大鼠骨髓间充质干细胞的分离及培养方法包括:The present invention realizes the separation and cultivation of a large number of primary bone marrow mesenchymal stem cells by extracting the mesenchymal stem cells present in the long bone marrow of rats, and provides a method for isolating and culturing rat bone marrow mesenchymal stem cells. The isolation and culture methods of bone marrow mesenchymal stem cells include:
步骤一,获取大鼠的离体的双侧股骨和胫骨,并剔除所述双侧股骨和胫骨表面的肌肉,并利用清洗液反复冲洗干净;(通过大鼠四肢长骨的获取,可显著提高原代间充质干细胞产量,剔除骨表面并清洗可排除肌肉、血管内皮、脂肪等细胞干扰原代细胞提取)Step 1, obtain the isolated bilateral femur and tibia of the rat, and remove the muscles on the surface of the bilateral femur and tibia, and use the cleaning solution to repeatedly rinse; (by obtaining the long bones of the limbs of the rat, the original The generation of mesenchymal stem cells, removal of the bone surface and cleaning can exclude muscle, vascular endothelial, fat and other cells that interfere with primary cell extraction)
步骤二,在无菌条件下,剪除所述双侧股骨和胫骨的两头,并利用清洗液多次冲洗股骨胫骨两端断口;(剪除关节面后,骨髓腔暴露,清洗液反复冲洗造血细胞等进一步排除干扰,提高原代骨髓间充质干细胞纯度)Step 2, under aseptic conditions, cut off the two ends of the bilateral femur and tibia, and use the cleaning solution to rinse the fractures at both ends of the femur and tibia several times; Further eliminate interference and improve the purity of primary bone marrow mesenchymal stem cells)
步骤三,将骨髓冲入培养液中,将细胞悬液直接接种于培养瓶中进行培养,待细胞80%汇合后胰蛋白酶消化传代培养;(细胞悬液接种至培养瓶中细胞生长速率较快,可快速扩增。)Step 3, the bone marrow is washed into the culture medium, and the cell suspension is directly inoculated in the culture flask for cultivation, and after the cells are 80% confluent, trypsinizes and subcultures; (the cell suspension is inoculated into the culture flask, and the cell growth rate is faster , allowing rapid amplification.)
步骤四,取健康生长第2代大鼠MSC制成细胞悬液移至离心管中,离心;弃上清液,用清洗液调整细胞浓度;(调整细胞浓度至合适浓度,传代扩增产量及速率提高)Step 4, take the second-generation rat MSCs of healthy growth to make a cell suspension, move it to a centrifuge tube, and centrifuge; discard the supernatant, and adjust the cell concentration with the cleaning solution; (adjust the cell concentration to an appropriate concentration, and the yield and speed increase)
步骤五,加入兔抗鼠CD45、CD44、CD90单克隆抗体,室温孵育,得到大鼠骨髓间充质干细胞。(因大鼠骨髓间充质干细胞表征为CD44(-),CD90(-),CD45(+),通过兔抗鼠CD45、CD44、CD90单克隆抗体可筛选骨髓间充质干细胞)Step five, adding rabbit anti-mouse CD45, CD44, CD90 monoclonal antibodies, incubating at room temperature, to obtain rat bone marrow mesenchymal stem cells. (Because rat bone marrow mesenchymal stem cells are characterized by CD44(-), CD90(-), CD45(+), bone marrow mesenchymal stem cells can be screened by rabbit anti-mouse CD45, CD44, CD90 monoclonal antibodies)
进一步,所述清洗液为PBS液。Further, the cleaning solution is PBS solution.
进一步,所述步骤三中,培养液为:DMEM培养液。Further, in the step three, the culture medium is: DMEM culture medium.
进一步,所述步骤三中,将细胞悬液直接接种于培养瓶中进行培养包括:24h后半换液。(半换液不仅可补充细胞生长营养物质,且保留间充质干细胞生长过程中分泌产生的外泌体、细胞外囊泡、microRNA等物质,细胞生长环境适宜)Further, in the third step, inoculating the cell suspension directly into the culture flask for culturing includes: changing the medium halfway after 24 hours. (The half-change solution can not only supplement the nutrients for cell growth, but also retain exosomes, extracellular vesicles, microRNA and other substances secreted during the growth of mesenchymal stem cells, and the cell growth environment is suitable)
进一步,所述步骤三中,胰蛋白酶浓度为2.5g/L。Further, in the third step, the concentration of trypsin is 2.5g/L.
进一步,所述步骤四中,离心包括:1000r/min离心5min。(离心速率较常规800r/min提高,提高离心后细胞获得量)Further, in step 4, the centrifugation includes: centrifugation at 1000 r/min for 5 minutes. (The centrifugation rate is higher than the conventional 800r/min, which increases the amount of cells obtained after centrifugation)
进一步,所述步骤四中,调整细胞浓度包括:调整细胞浓度为1×106。Further, in the step 4, adjusting the cell concentration includes: adjusting the cell concentration to 1×10 6 .
进一步,所述加入兔抗鼠CD45、CD44、CD90单克隆抗体包括:加入兔抗鼠CD45、CD44、CD90单克隆抗体各5μL。Further, the adding of rabbit anti-mouse CD45, CD44, and CD90 monoclonal antibodies includes: adding 5 μL each of rabbit anti-mouse CD45, CD44, and CD90 monoclonal antibodies.
进一步,所述步骤五中,室温孵育时间为15min。Further, in the step five, the incubation time at room temperature is 15 minutes.
进一步,所述室温孵育后还需进行:将孵育产物放入流式细胞仪中鉴定。Further, after the incubation at room temperature, it is necessary to carry out: putting the incubation product into a flow cytometer for identification.
结合上述的技术方案和解决的技术问题,请从以下几方面分析本发明所要保护的技术方案所具备的优点及积极效果为:Combining the above-mentioned technical solutions and technical problems to be solved, please analyze the advantages and positive effects of the technical solutions to be protected by the present invention from the following aspects:
第一、针对上述现有技术存在的技术问题以及解决该问题的难度,紧密结合本发明的所要保护的技术方案以及研发过程中结果和数据等,详细、深刻地分析本发明技术方案如何解决的技术问题,解决问题之后带来的一些具备创造性的技术效果。具体描述如下:First, in view of the technical problems existing in the above-mentioned prior art and the difficulty of solving the problems, closely combine the technical solution to be protected in the present invention and the results and data in the research and development process, etc., to analyze in detail how the technical solution of the present invention solves it Technical problems, some creative technical effects brought about after solving the problems. The specific description is as follows:
本发明提供了一种大鼠骨髓间充质干细胞的分离、培养及鉴定方法,操作简单,细胞产量和成活率高。The invention provides a method for isolating, cultivating and identifying rat bone marrow mesenchymal stem cells, which has simple operation and high cell yield and survival rate.
第二,把技术方案看做一个整体或者从产品的角度,本发明所要保护的技术方案具备的技术效果和优点,具体描述如下:Second, regarding the technical solution as a whole or from the perspective of a product, the technical effects and advantages of the technical solution to be protected by the present invention are specifically described as follows:
本发明的大鼠骨髓间充质干细胞的分离及培养方法是一种较为理想的大鼠骨髓间充质干细胞培养方法,可以满足多种生理生化实验的要求。The method for isolating and culturing rat bone marrow mesenchymal stem cells of the present invention is an ideal culture method for rat bone marrow mesenchymal stem cells, which can meet the requirements of various physiological and biochemical experiments.
第三,作为本发明的权利要求的创造性辅助证据,还体现在以下几个重要方面:本发明的技术方案转化后的预期收益和商业价值为:与现有分离培养方法相比,本发明所获得的大鼠骨髓MSCs纯度高,活力较强;且本发明培养细胞所需时间短,原代细胞培养7-8天后细胞即可生长至快速扩增期;对分离的细胞无损伤。具有稳定数量、高质量扩增培养大鼠骨髓MSCs需求,可高效满足多种生理生化实验的要求。Third, as an auxiliary evidence of the inventiveness of the claims of the present invention, it is also reflected in the following important aspects: the expected income and commercial value after the transformation of the technical solution of the present invention are: compared with the existing separation and cultivation methods, the The obtained rat bone marrow MSCs have high purity and strong vitality; and the time required for culturing cells in the present invention is short, and the cells can grow to the rapid expansion stage after the primary cells are cultured for 7-8 days; there is no damage to the isolated cells. It has the requirement of stable quantity and high-quality expansion and culture of rat bone marrow MSCs, and can efficiently meet the requirements of various physiological and biochemical experiments.
附图说明Description of drawings
图1是本发明实施例提供的大鼠骨髓间充质干细胞的分离及培养方法流程图;Fig. 1 is a flowchart of the method for isolating and culturing rat bone marrow mesenchymal stem cells provided by the embodiment of the present invention;
图2是本发明实施例提供的辐射对骨髓间充质干细胞旁分泌功能示意图;Fig. 2 is a schematic diagram of the paracrine function of radiation on bone marrow mesenchymal stem cells provided by the embodiment of the present invention;
图3是本发明实施例提供的实验结果示意图。Fig. 3 is a schematic diagram of the experimental results provided by the embodiment of the present invention.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.
一、解释说明实施例。为了使本领域技术人员充分了解本发明如何具体实现,该部分是对权利要求技术方案进行展开说明的解释说明实施例。1. Explain the embodiment. In order to make those skilled in the art fully understand how to implement the present invention, this part is an explanatory embodiment for explaining the technical solution of the claims.
如图1所示,本发明实施例提供的大鼠骨髓间充质干细胞的分离及培养方法包括:As shown in Figure 1, the method for isolating and culturing rat bone marrow mesenchymal stem cells provided by the embodiment of the present invention includes:
S101,获取大鼠离体的双侧股骨和胫骨,并剔除所述双侧股骨和胫骨表面的肌肉,并利用PBS液反复冲洗干净;S101, obtaining the isolated bilateral femur and tibia of the rat, removing the muscles on the surface of the bilateral femur and tibia, and repeatedly washing them with PBS;
S102,在无菌条件下,剪除所述双侧股骨和胫骨的两头,并利用PBS液多次冲洗股骨胫骨两端断口;S102, under aseptic conditions, cut off the two ends of the bilateral femur and tibia, and use PBS solution to wash the fracture at both ends of the femur and tibia multiple times;
S103,将骨髓冲入DMEM培养液中,将细胞悬液直接接种于培养瓶中进行培养,24h后半换液,待细胞80%汇合后以2.5g/L胰蛋白酶消化传代培养;S103, wash the bone marrow into the DMEM culture medium, inoculate the cell suspension directly into the culture flask for culture, change the medium after 24 hours, and digest and subculture with 2.5g/L trypsin after the cells are 80% confluent;
S104,取健康生长第2代大鼠MSC制成细胞悬液移至离心管中,1000r/min离心5min;弃上清液,用清洗液调整细胞浓度为1×106;S104, take the second-generation rat MSCs of healthy growth to make a cell suspension, transfer it to a centrifuge tube, and centrifuge at 1000r/min for 5min; discard the supernatant, and adjust the cell concentration to 1×10 6 with the cleaning solution;
S105,加入兔抗鼠CD45、CD44、CD90单克隆抗体各5μL,室温孵育15min,得到大鼠骨髓间充质干细胞。S105, add 5 μL each of rabbit anti-mouse CD45, CD44, and CD90 monoclonal antibodies, and incubate at room temperature for 15 minutes to obtain rat bone marrow mesenchymal stem cells.
本发明实施例提供的大鼠骨髓间充质干细胞的分离及培养方法包括:The method for isolating and culturing rat bone marrow mesenchymal stem cells provided in the embodiment of the present invention includes:
3%戊巴比妥钠按1mL/kg剂量腹腔麻醉SD大鼠。无菌操作下取双侧股骨和胫骨,剔除表面肌肉等,反复PBS液冲洗干净。无菌剪除股骨和胫骨两头,以PBS液多次冲洗股骨胫骨两端断口,将骨髓冲入DMEM培养液中,将细胞悬液直接接种培养瓶,24h后半换液,待细胞80%汇合后以2.5g/L胰蛋白酶消化传代培养。取健康生长第2代大鼠MSC制成细胞悬液移至离心管中,1000r/min离心5min。弃上清液,用PBS液调整细胞浓度为1×106。加入兔抗鼠CD45、CD44、CD90单克隆抗体各5μL,室温孵育15min,放入流式细胞仪中鉴定。SD rats were intraperitoneally anesthetized with 3% pentobarbital sodium at a dose of 1 mL/kg. The bilateral femur and tibia were taken under aseptic operation, the superficial muscles were removed, and washed with PBS solution repeatedly. Aseptically cut off the femur and tibia, rinse the fractures of both ends of the femur and tibia with PBS solution several times, pour the bone marrow into the DMEM culture medium, inoculate the cell suspension directly into the culture bottle, change the medium after 24 hours, and wait until the cells are 80% confluent Digest and subculture with 2.5g/L trypsin. The second generation of healthy rat MSCs was taken to make a cell suspension, transferred to a centrifuge tube, and centrifuged at 1000r/min for 5min. Discard the supernatant, and adjust the cell concentration to 1×10 6 with PBS. Add 5 μL each of rabbit anti-mouse CD45, CD44, and CD90 monoclonal antibodies, incubate at room temperature for 15 min, and put them into a flow cytometer for identification.
二、应用实施例:辐射对骨髓间充质干细胞旁分泌功能的影响研究中,利用该方法提取原代培养4d后可观察到细胞附壁铺伸,呈梭形,数量较多,局部呈多个散在分布的细胞集落。如图2所示,2. Application example: In the study of the effect of radiation on the paracrine function of bone marrow mesenchymal stem cells, the method can be used to extract the primary culture for 4 days, and it can be observed that the cells adhere to the wall and spread, showing a spindle shape, a large number, and a large number of local cells. scattered clusters of cells. as shown in picture 2,
为了证明本发明的技术方案的创造性和技术价值,该部分是对权利要求技术方案进行具体产品上或相关技术上的应用实施例。In order to prove the creativity and technical value of the technical solution of the present invention, this part is the application example of the claimed technical solution on specific products or related technologies.
三、实施例相关效果的证据。该方法第4~6天开始形成典型的、均匀分布的MSC簇状增殖灶,细胞数量增多,细胞形态呈长梭形,紧密排列,第6天后MSC数量迅速扩增,细胞簇状增生灶数量增加,范围扩大。第7~9天细胞生长即可达80%~90%的融合,呈长梭形,紧密排列类似旋涡状。传代细胞接种4h后开始附壁铺伸,12h活细胞基本完成附壁,第3天迅速增殖,第7天即可达到80%~90%的融合,呈比原代更均匀的长梭形。流式细胞术结果显示,所鉴定的细胞里,CD44(-),CD90(-),CD45(+),说明所培养的细胞确系MSC。PerCP-PE标记的CD90荧光;C:PerCP-FITC(异硫氰酸荧光素)标记的CD45荧光;D:PerCP-FITC标记的CD44荧光。如图3所示。3. Evidence of the relevant effects of the embodiment. This method begins to form typical, uniformly distributed MSC cluster proliferation foci on the 4th to 6th day, the number of cells increases, and the cell shape is long spindle-shaped and closely arranged. increased, the scope expanded. On the 7th to 9th day, the cells can grow to reach 80% to 90% confluence, showing a long spindle shape, closely arranged like a whirlpool. 4 hours after inoculation, the subcultured cells began to adhere to the wall, and 12 hours after the living cells basically completed the wall, proliferated rapidly on the 3rd day, and reached 80% to 90% confluence on the 7th day, showing a more uniform long spindle shape than the primary one. The results of flow cytometry showed that among the identified cells, CD44(-), CD90(-), and CD45(+), indicating that the cultured cells were indeed MSCs. PerCP-PE labeled CD90 fluorescence; C: PerCP-FITC (fluorescein isothiocyanate) labeled CD45 fluorescence; D: PerCP-FITC labeled CD44 fluorescence. As shown in Figure 3.
本发明实施例在研发或者使用过程中取得了一些积极效果,和现有技术相比的确具备很大的优势,下面内容结合试验过程的数据、图表等进行描述。The embodiment of the present invention has achieved some positive effects in the process of research and development or use, and indeed has great advantages compared with the prior art. The following content is described in conjunction with the data and charts of the test process.
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,都应涵盖在本发明的保护范围之内。The above is only a specific embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Anyone familiar with the technical field within the technical scope disclosed in the present invention, whoever is within the spirit and principles of the present invention Any modifications, equivalent replacements and improvements made within shall fall within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211683600.3A CN115992091A (en) | 2022-12-27 | 2022-12-27 | A method for isolating and culturing rat bone marrow mesenchymal stem cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211683600.3A CN115992091A (en) | 2022-12-27 | 2022-12-27 | A method for isolating and culturing rat bone marrow mesenchymal stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115992091A true CN115992091A (en) | 2023-04-21 |
Family
ID=85991590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211683600.3A Pending CN115992091A (en) | 2022-12-27 | 2022-12-27 | A method for isolating and culturing rat bone marrow mesenchymal stem cells |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115992091A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119015315A (en) * | 2024-08-16 | 2024-11-26 | 广州众乐国际生物科技有限公司 | Albumin composition for assisting in promoting human hormone secretion and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109706115A (en) * | 2017-10-26 | 2019-05-03 | 中国医科大学 | A method for constructing a mouse bone marrow mesenchymal stem cell line |
-
2022
- 2022-12-27 CN CN202211683600.3A patent/CN115992091A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109706115A (en) * | 2017-10-26 | 2019-05-03 | 中国医科大学 | A method for constructing a mouse bone marrow mesenchymal stem cell line |
Non-Patent Citations (2)
Title |
---|
卞铁荣等: "SD大鼠骨髓间充质干细胞与其乳鼠该细胞株的细胞表型鉴定比较", 广东医学, vol. 34, no. 22, 25 November 2013 (2013-11-25), pages 3397 - 3398 * |
李丹等: "大鼠骨髓间充质干细胞体外培养体系的建立", 济宁医学院学报, vol. 38, no. 05, 20 October 2015 (2015-10-20), pages 321 - 322 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119015315A (en) * | 2024-08-16 | 2024-11-26 | 广州众乐国际生物科技有限公司 | Albumin composition for assisting in promoting human hormone secretion and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104630144B (en) | A kind of separation of umbilical cord blood mesenchymal stem cellses and cultural method | |
WO2016049986A1 (en) | Method for separating umbilical cord mesenchymal stem cells | |
CN110564682B (en) | Method for large-scale production of human adipose-derived mesenchymal stem cell exosomes | |
CN106754674A (en) | Method and its application of amnion mesenchymal stem cell are prepared from Human plactnta amnion | |
CN101914490A (en) | A kind of human amniotic membrane mesenchymal stem cell serum-free medium and culture method thereof | |
CN102978156A (en) | Expansion in vitro purification culture method of mesenchymal stem cells and culture medium | |
CN105543164A (en) | Primary isolated culture method for dairy cow mammary epithelial cells | |
CN106754668A (en) | A kind of stem cell medium and parenteral solution | |
CN104450611A (en) | Primary separation and culture method of human amniotic mesenchymal stem cells | |
CN111925982A (en) | Human bone marrow mesenchymal stem cell culture process applying three-dimensional cells | |
CN102154200B (en) | Preparation and storage of mesenchymal stem cells for clinical treatment | |
CN108220229A (en) | A kind of preparation method for improving umbilical cord derived mesenchymal stem cell primary cell yield | |
CN105087474A (en) | Culture method of deciduous tooth pulp stem cells | |
CN107267453A (en) | A kind of culture medium and its application for being used to cultivate fat mesenchymal stem cell | |
CN113564109A (en) | Preparation method of menstrual blood mesenchymal stem cells | |
CN101372682B (en) | Construction method of Epinephelus fuscoguttatus fin cell line | |
CN115992091A (en) | A method for isolating and culturing rat bone marrow mesenchymal stem cells | |
CN115521909A (en) | Preparation method and application of synovial membrane mesenchymal stem cells | |
CN101760445B (en) | Method for amplifying autologous bone marrow mesenchymal stem cells | |
CN109897815A (en) | It is a kind of without coated fatty endothelial progenitor cells efficiently separate and cultural method | |
CN118147046A (en) | Method for separating and culturing hair follicle stem cells from scalp tissue and application | |
CN112941017A (en) | Culture medium for inducing human mesenchymal stem cells to form fat and differentiate and preparation method thereof | |
CN108034634B (en) | Method for separating endometrial mesenchymal stem cells from menstrual blood | |
CN102119936B (en) | Method for preparing injection for treating ischemic brain damage by using human amniotic mesenchymal cells and injection | |
CN104818243A (en) | Separation method of placenta-derived fetal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |